Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease - Verma, S; Mazer, C D; Yan, A T (Circulation, 2019)
. doi:10.1161/CIRCULATIONAHA.119.042375